Selected research
Market Outlook & Growth Opportunities
Global AI Telehealth Platforms Market Outlook and Growth Opportunities 2026
Market perspective
The global AI Telehealth Platforms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for AI Telehealth Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Telehealth Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Telehealth Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the AI Telehealth Platforms market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the AI Telehealth Platforms market include Teladoc Health, Inc., Amwell (American Well Corporation), Philips Healthcare, Siemens Healthineers, GE Healthcare Technologies, IBM Corporation (Watson Health), Microsoft Corporation (Azure Health / Healthcare AI), Oracle Health and Epic Systems Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global AI Telehealth Platforms market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Telehealth Platforms and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Telehealth Platforms revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Telehealth Platforms market.
AI Telehealth Platforms Segment by Company
Teladoc Health, Inc.
Amwell (American Well Corporation)
Philips Healthcare
Siemens Healthineers
GE Healthcare Technologies
IBM Corporation (Watson Health)
Microsoft Corporation (Azure Health / Healthcare AI)
Oracle Health
Epic Systems Corporation
Cisco Systems, Inc.
Ping An Good Doctor
Included Health, Inc.
Doximity, Inc.
HealthTap, Inc.
Ada Health GmbH
AI Telehealth Platforms Segment by Type
Cloud-Based / SaaS
On-Premises / Enterprise
AI Telehealth Platforms Segment by Application
Hospitals & Clinics
Insurers & Health Networks
Direct-to-Consumer / Patients
AI Telehealth Platforms Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global AI Telehealth Platforms status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the AI Telehealth Platforms key companies, revenue, market share, and recent developments.
3. To split the AI Telehealth Platforms breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions AI Telehealth Platforms market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify AI Telehealth Platforms significant trends, drivers, influence factors in global and regions.
6. To analyze AI Telehealth Platforms competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Telehealth Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Telehealth Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Telehealth Platforms.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Telehealth Platforms industry.
Chapter 3: Detailed analysis of AI Telehealth Platforms company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of AI Telehealth Platforms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of AI Telehealth Platforms in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based / SaaS
- On-Premises / Enterprise
Applications
- Hospitals & Clinics
- Insurers & Health Networks
- Direct-to-Consumer / Patients
Companies covered
- Teladoc Health, Inc.
- Amwell (American Well Corporation)
- Philips Healthcare
- Siemens Healthineers
- GE Healthcare Technologies
- IBM Corporation (Watson Health)
- Microsoft Corporation (Azure Health / Healthcare AI)
- Oracle Health
- Epic Systems Corporation
- Cisco Systems, Inc.
- Ping An Good Doctor
- Included Health, Inc.
- Doximity, Inc.
- HealthTap, Inc.
- Ada Health GmbH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global AI Telehealth Platforms Market Size, 2021 VS 2025 VS 2032
- 1.3 Global AI Telehealth Platforms Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI Telehealth Platforms Market Dynamics
- 2.1 AI Telehealth Platforms Industry Trends
- 2.2 AI Telehealth Platforms Industry Drivers
- 2.3 AI Telehealth Platforms Industry Opportunities and Challenges
- 2.4 AI Telehealth Platforms Industry Restraints
3 AI Telehealth Platforms Market by Company
- 3.1 Global AI Telehealth Platforms Company Revenue Ranking in 2025
- 3.2 Global AI Telehealth Platforms Revenue by Company (2021-2026)
- 3.3 Global AI Telehealth Platforms Company Ranking (2024-2026)
- 3.4 Global AI Telehealth Platforms Company Manufacturing Base and Headquarters
- 3.5 Global AI Telehealth Platforms Company Product Type and Application
- 3.6 Global AI Telehealth Platforms Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global AI Telehealth Platforms Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 AI Telehealth Platforms Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 AI Telehealth Platforms Market by Type
- 4.1 AI Telehealth Platforms Type Introduction
- 4.1.1 Cloud-Based / SaaS
- 4.1.2 On-Premises / Enterprise
- 4.2 Global AI Telehealth Platforms Sales Value by Type
- 4.2.1 Global AI Telehealth Platforms Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global AI Telehealth Platforms Sales Value by Type (2021-2032)
- 4.2.3 Global AI Telehealth Platforms Sales Value Share by Type (2021-2032)
5 AI Telehealth Platforms Market by Application
- 5.1 AI Telehealth Platforms Application Introduction
- 5.1.1 Hospitals & Clinics
- 5.1.2 Insurers & Health Networks
- 5.1.3 Direct-to-Consumer / Patients
- 5.2 Global AI Telehealth Platforms Sales Value by Application
- 5.2.1 Global AI Telehealth Platforms Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global AI Telehealth Platforms Sales Value by Application (2021-2032)
- 5.2.3 Global AI Telehealth Platforms Sales Value Share by Application (2021-2032)
6 AI Telehealth Platforms Regional Value Analysis
- 6.1 Global AI Telehealth Platforms Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global AI Telehealth Platforms Sales Value by Region (2021-2032)
- 6.2.1 Global AI Telehealth Platforms Sales Value by Region: 2021-2026
- 6.2.2 Global AI Telehealth Platforms Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America AI Telehealth Platforms Sales Value (2021-2032)
- 6.3.2 North America AI Telehealth Platforms Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe AI Telehealth Platforms Sales Value (2021-2032)
- 6.4.2 Europe AI Telehealth Platforms Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific AI Telehealth Platforms Sales Value (2021-2032)
- 6.5.2 Asia-Pacific AI Telehealth Platforms Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America AI Telehealth Platforms Sales Value (2021-2032)
- 6.6.2 South America AI Telehealth Platforms Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa AI Telehealth Platforms Sales Value (2021-2032)
- 6.7.2 Middle East & Africa AI Telehealth Platforms Sales Value Share by Country, 2025 VS 2032
7 AI Telehealth Platforms Country-level Value Analysis
- 7.1 Global AI Telehealth Platforms Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global AI Telehealth Platforms Sales Value by Country (2021-2032)
- 7.2.1 Global AI Telehealth Platforms Sales Value by Country (2021-2026)
- 7.2.2 Global AI Telehealth Platforms Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.3.2 USA AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.7.2 France AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.14.2 China AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.17.2 India AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt AI Telehealth Platforms Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt AI Telehealth Platforms Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt AI Telehealth Platforms Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Teladoc Health, Inc.
- 8.1.1 Teladoc Health, Inc. Company Information
- 8.1.2 Teladoc Health, Inc. Business Overview
- 8.1.3 Teladoc Health, Inc. AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.1.4 Teladoc Health, Inc. AI Telehealth Platforms Product Portfolio
- 8.1.5 Teladoc Health, Inc. Recent Developments
- 8.2 Amwell (American Well Corporation)
- 8.2.1 Amwell (American Well Corporation) Company Information
- 8.2.2 Amwell (American Well Corporation) Business Overview
- 8.2.3 Amwell (American Well Corporation) AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.2.4 Amwell (American Well Corporation) AI Telehealth Platforms Product Portfolio
- 8.2.5 Amwell (American Well Corporation) Recent Developments
- 8.3 Philips Healthcare
- 8.3.1 Philips Healthcare Company Information
- 8.3.2 Philips Healthcare Business Overview
- 8.3.3 Philips Healthcare AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.3.4 Philips Healthcare AI Telehealth Platforms Product Portfolio
- 8.3.5 Philips Healthcare Recent Developments
- 8.4 Siemens Healthineers
- 8.4.1 Siemens Healthineers Company Information
- 8.4.2 Siemens Healthineers Business Overview
- 8.4.3 Siemens Healthineers AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.4.4 Siemens Healthineers AI Telehealth Platforms Product Portfolio
- 8.4.5 Siemens Healthineers Recent Developments
- 8.5 GE Healthcare Technologies
- 8.5.1 GE Healthcare Technologies Company Information
- 8.5.2 GE Healthcare Technologies Business Overview
- 8.5.3 GE Healthcare Technologies AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.5.4 GE Healthcare Technologies AI Telehealth Platforms Product Portfolio
- 8.5.5 GE Healthcare Technologies Recent Developments
- 8.6 IBM Corporation (Watson Health)
- 8.6.1 IBM Corporation (Watson Health) Company Information
- 8.6.2 IBM Corporation (Watson Health) Business Overview
- 8.6.3 IBM Corporation (Watson Health) AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.6.4 IBM Corporation (Watson Health) AI Telehealth Platforms Product Portfolio
- 8.6.5 IBM Corporation (Watson Health) Recent Developments
- 8.7 Microsoft Corporation (Azure Health / Healthcare AI)
- 8.7.1 Microsoft Corporation (Azure Health / Healthcare AI) Company Information
- 8.7.2 Microsoft Corporation (Azure Health / Healthcare AI) Business Overview
- 8.7.3 Microsoft Corporation (Azure Health / Healthcare AI) AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.7.4 Microsoft Corporation (Azure Health / Healthcare AI) AI Telehealth Platforms Product Portfolio
- 8.7.5 Microsoft Corporation (Azure Health / Healthcare AI) Recent Developments
- 8.8 Oracle Health
- 8.8.1 Oracle Health Company Information
- 8.8.2 Oracle Health Business Overview
- 8.8.3 Oracle Health AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.8.4 Oracle Health AI Telehealth Platforms Product Portfolio
- 8.8.5 Oracle Health Recent Developments
- 8.9 Epic Systems Corporation
- 8.9.1 Epic Systems Corporation Company Information
- 8.9.2 Epic Systems Corporation Business Overview
- 8.9.3 Epic Systems Corporation AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.9.4 Epic Systems Corporation AI Telehealth Platforms Product Portfolio
- 8.9.5 Epic Systems Corporation Recent Developments
- 8.10 Cisco Systems, Inc.
- 8.10.1 Cisco Systems, Inc. Company Information
- 8.10.2 Cisco Systems, Inc. Business Overview
- 8.10.3 Cisco Systems, Inc. AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.10.4 Cisco Systems, Inc. AI Telehealth Platforms Product Portfolio
- 8.10.5 Cisco Systems, Inc. Recent Developments
- 8.11 Ping An Good Doctor
- 8.11.1 Ping An Good Doctor Company Information
- 8.11.2 Ping An Good Doctor Business Overview
- 8.11.3 Ping An Good Doctor AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.11.4 Ping An Good Doctor AI Telehealth Platforms Product Portfolio
- 8.11.5 Ping An Good Doctor Recent Developments
- 8.12 Included Health, Inc.
- 8.12.1 Included Health, Inc. Company Information
- 8.12.2 Included Health, Inc. Business Overview
- 8.12.3 Included Health, Inc. AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.12.4 Included Health, Inc. AI Telehealth Platforms Product Portfolio
- 8.12.5 Included Health, Inc. Recent Developments
- 8.13 Doximity, Inc.
- 8.13.1 Doximity, Inc. Company Information
- 8.13.2 Doximity, Inc. Business Overview
- 8.13.3 Doximity, Inc. AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.13.4 Doximity, Inc. AI Telehealth Platforms Product Portfolio
- 8.13.5 Doximity, Inc. Recent Developments
- 8.14 HealthTap, Inc.
- 8.14.1 HealthTap, Inc. Company Information
- 8.14.2 HealthTap, Inc. Business Overview
- 8.14.3 HealthTap, Inc. AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.14.4 HealthTap, Inc. AI Telehealth Platforms Product Portfolio
- 8.14.5 HealthTap, Inc. Recent Developments
- 8.15 Ada Health GmbH
- 8.15.1 Ada Health GmbH Company Information
- 8.15.2 Ada Health GmbH Business Overview
- 8.15.3 Ada Health GmbH AI Telehealth Platforms Revenue and Gross Margin (2021-2026)
- 8.15.4 Ada Health GmbH AI Telehealth Platforms Product Portfolio
- 8.15.5 Ada Health GmbH Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst